...
机译:177177 177 177 177 177的Lu-Dotatate PRRT在生长抑素受体阳性转移性髓质癌的甲状腺患者的疗效,生存分析,预后变量和毒性患者
Radiation Medicine Centre Bhabha Atomic Research CentreTata Memorial Centre AnnexeMumbai India;
Radiation Medicine Centre Bhabha Atomic Research CentreTata Memorial Centre AnnexeMumbai India;
Homi Bhabha National InstituteMumbai India;
Homi Bhabha National InstituteMumbai India;
Homi Bhabha National InstituteMumbai India;
Radiation Medicine Centre Bhabha Atomic Research CentreTata Memorial Centre AnnexeMumbai India;
Radiation Medicine Centre Bhabha Atomic Research CentreTata Memorial Centre AnnexeMumbai India;
177 Lu‐DOTATATE; 68 Ga‐DOTATATE PET‐CT; calcitonin doubling time; medullary thyroid carcinoma; peptide receptor radionuclide therapy; progression‐free survival and overall survival;
机译:177177 177 177 177 177的Lu-Dotatate PRRT在生长抑素受体阳性转移性髓质癌的甲状腺患者的疗效,生存分析,预后变量和毒性患者
机译:Lu-177-DOTATATE与Lu-177-EDTMP与鸡尾酒/序贯疗法在甲状腺髓样癌和神经内分泌肿瘤的骨限制性疼痛转移性疾病中的应用:可以半定量比较Ga-68-DOTATATE和F-18-氟化物PET- CT在选择最佳治疗方案时是否有助于个性化治疗决策?
机译:177Lu Dotatate对比顺序177Lu Dotatate和90Y Dotatate:科视Christie PRRT患者的治疗结果-临床审核
机译:〜(177)Lu-DOTA-J591单克隆抗体:化学,毒性,剂量和临床疗效:使用〜(177)LU-J591抗-PSMA抗体的前列腺癌
机译:[177Lu] -DOTATATE进行PRRT的患者中生长抑素受体表达的治疗内异质性与形态学治疗反应的相关性
机译:PRRT的标准活性为177Lu-奥曲肽是否真的能在靶肿瘤病变中达到相关的生长抑素受体饱和度?